NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 32,050
+1,000 (3.22%)
At close: Feb 27, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 364.28 billion as of February 27, 2026. Its market cap has increased by 122.79% in one year.
Market Cap
364.28B
Enterprise Value
347.81B
Revenue
32.96B
Ranking
n/a
PE Ratio
116.99
Stock Price
32,050.00
Market Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 364.28B, an increase of 873.12%. That is a compound annual growth rate of 16.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 364.28B | -14.62% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 472.49B |
| curacle co.,ltd. | 393.72B |
| Y-Biologics | 388.56B |
| ABION | 284.27B |
| Genome & Company | 221.92B |
| ISU Abxis | 219.48B |
| QuadMedicine | 217.24B |
| Bio Solution | 216.34B |